Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
The Annals of Thoracic Surgery|May 29, 2012
Midterm benefits of preoperative statin therapy in patients undergoing isolated valve surgeryMuthiah Vaduganathan, Neil J Stone, Adin-Cristian Andrei, et al.American Journal of Preventive Cardiology|July 30, 2021
Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendationsDavid I Feldman, Erin D Michos, Neil J Stone, et al.Journal of Vascular Surgery|August 13, 2013
Statin use and lower extremity amputation risk in nonelderly diabetic patientsMin-Woong Sohn, Judith L Meadows, Elissa H Oh, et al.Journal of the American Heart Association|October 1, 2020
Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015Martin Tibuakuu, Victor Okunrintemi, Nazir Savji, et al.Journal of the American College of Cardiology|April 4, 2015
Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA GuidelinesSeth S Martin, Laurence S Sperling, Michael J Blaha, et al.American Journal of Medicine Open|March 19, 2025
Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Case-Based Narrative ReviewAamir Javaid, Essa Hariri, Bige Ozkan, et al.The Journal of Pediatrics|July 26, 2011
Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositisMicah J Eimer, Wendy J Brickman, Roopa Seshadri, et al.JAMA Cardiology|April 11, 2019
Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood CholesterolSarah Chuzi, Anna Pfenniger, Donald M Lloyd-Jones, et al.American Heart Journal|June 19, 2022
Statin-associated muscle symptoms in the VITamin D and OmegA-3 TriaL (VITAL)Pedro Engel Gonzalez, Mark A Hlatky, JoAnn E Manson, et al.European Heart Journal|January 19, 2021
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterolAngelos D Karagiannis, Anurag Mehta, Devinder S Dhindsa, et al.Pageof 12